DA Vallera

2.0k total citations
45 papers, 1.7k citations indexed

About

DA Vallera is a scholar working on Immunology, Hematology and Biotechnology. According to data from OpenAlex, DA Vallera has authored 45 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Immunology, 25 papers in Hematology and 12 papers in Biotechnology. Recurrent topics in DA Vallera's work include Hematopoietic Stem Cell Transplantation (24 papers), Toxin Mechanisms and Immunotoxins (19 papers) and Immune Cell Function and Interaction (12 papers). DA Vallera is often cited by papers focused on Hematopoietic Stem Cell Transplantation (24 papers), Toxin Mechanisms and Immunotoxins (19 papers) and Immune Cell Function and Interaction (12 papers). DA Vallera collaborates with scholars based in United States and United Kingdom. DA Vallera's co-authors include BR Blazar, PA Taylor, BR Blazar, Fatih M. Uckun, JH Kersey, Angela Panoskaltsis‐Mortari, Sidney R. Smith, R Haake, NK Ramsay and MB Widmer and has published in prestigious journals such as Blood, Cancer Biotherapy and Radiopharmaceuticals and PubMed.

In The Last Decade

DA Vallera

45 papers receiving 1.6k citations

Peers

Countries citing papers authored by DA Vallera

Since Specialization

Citations

This map shows the geographic impact of DA Vallera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DA Vallera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DA Vallera more than expected).

Fields of papers citing papers by DA Vallera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by DA Vallera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DA Vallera. The network helps show where DA Vallera may publish in the future.

Co-authorship network of co-authors of DA Vallera

This figure shows the co-authorship network connecting the top 25 collaborators of DA Vallera. A scholar is included among the top collaborators of DA Vallera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with DA Vallera. DA Vallera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preclinical Studies Targeting Normal and Leukemic Hematopoietic Cells with Yttrium-90-Labeled anti-CD45 Antibody in Vitro and in Vivo in Nude Mice 2003 ·Cancer Biotherapy and Radiopharmaceuticals ·DA Vallera, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), NK Ramsay, Angela Panoskaltsis‐Mortari, (unknown), JE Wagner, JH Kersey	6
2	Anti-graft-versus-host disease effect of DT390-anti-CD3sFv, a single- chain Fv fusion immunotoxin specifically targeting the CD3 epsilon moiety of the T-cell receptor 1996 ·Blood ·DA Vallera, Angela Panoskaltsis‐Mortari, Carolina R. Jost, Sundaram Ramakrishnan, (unknown), RJ Kreitman, (unknown), Christopher A. Pennell, BR Blazar	23
3	A murine cytokine fusion toxin specifically targeting the murine granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor on normal committed bone marrow progenitor cells and GM-CSF-dependent tumor cells 1995 ·Blood ·(unknown), BR Blazar, (unknown), RJ Kreitman, DA Vallera	4
4	Adult bone marrow-derived pluripotent hematopoietic stem cells are engraftable when transferred in utero into moderately anemic fetal recipients 1995 ·Blood ·BR Blazar, PA Taylor, DA Vallera	50
5	A murine cytokine fusion toxin specifically targeting the murine granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor on normal committed bone marrow progenitor cells and GM-CSF-dependent tumor cells 1995 ·Blood ·(unknown), BR Blazar, (unknown), RJ Kreitman, DA Vallera	31
6	Immunotoxins: will their clinical promise be fulfilled? [editorial] 1994 ·Blood ·DA Vallera	32
7	In vivo blockade of CD28/CTLA4: B7/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice 1994 ·Blood ·BR Blazar, PA Taylor, (unknown), DA Vallera	185
8	Retroviral-mediated transfer of the murine interleukin-3 gene engineered for intracellular retention results in a myeloproliferative syndrome but is associated with circulating interleukin-3 levels. 1993 ·PubMed ·(unknown), (unknown), Keith Gorden, Cynthia E. Dunbar, DA Vallera, Peter C. Taylor, (unknown), (unknown)	9
9	Promotion of murine marrow alloengraftment and hematopoietic recovery across the major histocompatibility barrier by administration of recombinant human interleukin-1 alpha [see comments] 1992 ·Blood ·BR Blazar, MB Widmer, PA Taylor, DA Vallera	12
10	Prevention of murine graft-versus-host disease and bone marrow alloengraftment across the major histocompatibility barrier after donor graft preincubation with anti-LFA1 immunotoxin 1991 ·Blood ·BR Blazar, (unknown), DA Vallera	13
11	Pretreatment of murine donor grafts with L-leucyl-L-leucine methyl ester: elimination of graft-versus-host disease without detrimental effects on engraftment 1990 ·Blood ·BR Blazar, (unknown), DA Vallera	23
12	Autologous bone marrow transplantation in high-risk remission T-lineage acute lymphoblastic leukemia using immunotoxins plus 4- hydroperoxycyclophosphamide for marrow purging 1990 ·Blood ·Fatih M. Uckun, JH Kersey, DA Vallera, (unknown), Daniel J. Weisdorf, Damian E. Myers, R Haake, NK Ramsay	74
13	Improved survival and leukocyte reconstitution without detrimental effects on engraftment in murine recipients of human recombinant granulocyte colony-stimulating factor after transplantation of T-cell- depleted histoincompatible bone marrow 1989 ·Blood ·BR Blazar, MB Widmer, (unknown), (unknown), DA Vallera	13
14	In vivo administration of recombinant human granulocyte/macrophage colony-stimulating factor in acute lymphoblastic leukemia patients receiving purged autografts [see comments] 1989 ·Blood ·BR Blazar, JH Kersey, (unknown), DA Vallera, LC Lasky, R Haake, Bruce Bostrom, (unknown), (unknown), NK Ramsay	1
15	Cell-type-specific cytotoxicity of anti-CD4 and anti-CD8 ricin immunotoxins against human alloreactive T-cell clones 1989 ·Blood ·Fatih M. Uckun, Damian E. Myers, (unknown), (unknown), DA Vallera	7
16	In vivo administration of recombinant human granulocyte/macrophage colony-stimulating factor in acute lymphoblastic leukemia patients receiving purged autografts [see comments] 1989 ·Blood ·BR Blazar, JH Kersey, (unknown), DA Vallera, LC Lasky, R Haake, Bruce Bostrom, (unknown), (unknown), NK Ramsay	92
17	Augmentation of donor bone marrow engraftment in histoincompatible murine recipients by granulocyte/macrophage colony-stimulating factor 1988 ·Blood ·BR Blazar, MB Widmer, (unknown), DL Urdal, Steven Gillis, (unknown), DA Vallera	48
18	Enhanced survival but reduced engraftment in murine recipients of recombinant granulocyte/macrophage colony-stimulating factor following transplantation of T-cell-depleted histoincompatible bone marrow 1988 ·Blood ·BR Blazar, MB Widmer, (unknown), Steven Gillis, DA Vallera	22
19	Augmentation of donor bone marrow engraftment in histoincompatible murine recipients by granulocyte/macrophage colony-stimulating factor 1988 ·Blood ·BR Blazar, MB Widmer, (unknown), DL Urdal, Steven Gillis, (unknown), DA Vallera	10
20	Marrow purging in autologous bone marrow transplantation for T-lineage acute lymphoblastic leukemia: efficacy of ex vivo treatment with immunotoxins and 4-hydroperoxycyclophosphamide against fresh leukemic marrow progenitor cells 1987 ·Blood ·Fatih M. Uckun, (unknown), (unknown), (unknown), JH Kersey, (unknown), DA Vallera	67

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact